RESULTS International, The ONE Campaign and Global Poverty Project's partnership means a win for vaccines

WHAT'S THE COMMITMENT?

Amazing news, global citizens!

On March 4, President Obama released his fiscal year 2015 budget, which included $200 million to increase access to vaccines in developing countries.

Photo: The Measles Initiative/C. McNab/2011 |A young woman in Laos walks away after immunisation against measles and rubella at Kang village school in Pakse District, southern Laos, during an immunisation campaign in November 2011. 

HOW DID GLOBAL CITIZENS RESPOND?

The budget request proposes $200 million in funding for Gavi, the Vaccine Alliance, a public-private global health partnership committed to increasing access to immunization in developing countries, and partner with Global Poverty Project.

Every child, no matter where he or she is born, has the right to the opportunity of a healthy life and vaccines are one of the best ways to assure it. Since its launch in 2000, the Gavi Alliance has contributed to the immunization of an additional 440 million children and helped countries prevent more than 6 million deaths.

Photo: Gavi/11/Doune Porter | January 2011, Yemen – Baby Rinad was the first child in Yemen to get the pneumococcal vaccine shot.

However, 22.6 million children around the world still don’t have access to the most basic vaccines. One in five of all children who die before the age of five lose their lives to vaccine-preventable diseases. The overwhelming majority of these deaths occur in developing countries.

WHAT'S THE IMPACT?

President’s Obama’s request represents a $25 million increase from the current year’s funding. This is a huge signal of U.S. support for ending child deaths!

WHAT HAPPENS NEXT?

But our work isn’t over yet. Over the next few months we need your help to ensure that Congressional leaders understand the importance of funding vaccines and immunizations. Take action now by signing our petition.

Editorial

Defeat Poverty

President Obama makes an historic $200M request for vaccines